Overview: FDA Notice on Prazosin Hydrochloride Recall The U.S. Food and Drug Administration (FDA) has announced the recall of more than 500,000 bottles of the blood pressure medication prazosin hydrochloride. The recall stems from concerns that the drug may contain a cancer-causing impurity, prompting manufacturers to pull affected lots from the market and instruct patients…